Revenue and EBITDA declined year-over-year due to operational disruptions and cost inflation, but sequential improvements and strong growth in Packaging and Tissue segments highlight resilience. Strategic investments in sustainability and innovation continue, with positive outlooks for price and demand in key segments.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.